GlassScriptPhysician profile
Khoi M Le
NPI 1629048012
$17,662.81
in general payments reported to CMS, 2019-2025
36 companies · $1,116 in 2025
The $1,116 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,496 · 2020: $2,155 · 2021: $2,534 · 2022: $3,717 · 2023: $2,542 · 2024: $2,102 · 2025: $1,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,760.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,334.32 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,706.99 | 2019-2025 | Gallant, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Biotronik INC. | $1,458.90 | 2019-2023 | Rivacor 7 Dr-T, Selectra |
| Lilly USA, LLC | $1,266.15 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $860.92 | 2020-2025 | Nexletol |
| Abiomed | $773.96 | 2019-2025 | Impella |
| Amarin Pharma, INC. | $756.98 | 2019-2023 | |
| Novo Nordisk INC | $731.42 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $678.51 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $630.30 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $451.56 | 2019-2023 | Invega Sustenna, Invega Trinza, Xarelto |
| Merck Sharp & Dohme LLC | $386.38 | 2021-2023 | Verquvo |
| Pfizer INC. | $335.62 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $274.98 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $266.18 | 2019-2023 | Farxiga |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $219.85 | 2022-2023 | |
| Medtronic, INC. | $213.60 | 2022-2024 | Selectsecure, Attain Command + Surevalve |
| Bayer Healthcare Pharmaceuticals INC. | $208.66 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $141.33 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $139.73 | 2019-2022 | |
| Lundbeck LLC | $100.63 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $98.80 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $86.38 | 2022-2023 | Eliquis |
| Alnylam Pharmaceuticals INC. | $85.05 | 2021-2025 | Amvuttra |
| Boston Scientific Corporation | $69.59 | 2022-2025 | Watchman Flx |
| Cvrx, INC. | $69.16 | 2023-2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $59.41 | 2023-2024 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $49.07 | 2021-2022 | |
| Philips North America LLC | $42.33 | 2020 | |
| Scpharmaceuticals INC. | $33.83 | 2023-2025 | |
| Edwards Lifesciences Corporation | $29.81 | 2021 | |
| Chiesi USA, INC. | $24.35 | 2025 | Juxtapid |
| Medtronic Vascular, INC. | $23.97 | 2019 | |
| Elutia, INC. | $22.01 | 2021 | |
| Bardy Diagnostics, INC. | $18.75 | 2020 | |
| Tactile Systems Technology INC | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khoi Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.